This site is intended for healthcare professionals only
LoginRegister
Submit More Data:  CDSCO Panel tells Boehringer Ingelheim on Veterinary Drug AfoxolanerSubmit More Data:  CDSCO Panel tells Boehringer Ingelheim on Veterinary Drug Afoxolaner
Intas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic DermatitisIntas Pharmaceuticals Gets CDSCO Panel Nod To study Bevacizumab Solution for Injection
Cardiac, GI Power Indian Pharma Markets 7.5% March SurgeIndian Pharma market to expand by 8-9 percent in FY26: Report
Zydus Lifesciences receives tentative approval from USFDA for Chronic lymphocytic leukaemia drug IbrutinibZydus Lifesciences bags USFDA approval for urinary tract infections drug
48 projects approved to avoid disruption in critical APIs supplyIndian pharma exports secured 11th position globally in 2023, says Minister
CDSCO Panel Clears AstraZenecas Datopotamab for Breast Cancer, Seeks Phase IV TrialAstraZeneca-Ionis Pharma Wainzua approved in EU for hereditary transthyretin-mediated amyloidosis in...
Hetero Labs Acarbose-Sitagliptin-Metformin FDC Rejected by CDSCO Panel Over GI RiskHetero Healthcare Gets CDSCO Panel Nod To Conduct Phase III clinical trial of Tioconazole vaginal...
Mylan Pharmaceutical Gets CDSCO Panel Nod To study SelatogrelMylan Pharmaceutical Gets CDSCO Panel Nod To study Selatogrel
Fresenius Told To Submit Approval Basis, Phase III Data for Calcium Chloride Dihydrate Infusion ProposalBlacklisted Drugs Used, 33%-47% Essential Medicines Unavailable, Delhi Still Using 1994 Drug...
Zydus enters exclusive negotiations with PAI Partners, other shareholders to acquire majority stake in Amplitude SurgicalZydus Lifesciences to acquire Amplitude Surgical for Rs 2,447 crore
Gland Pharma Pashamylaram facility receives GMP compliance certificate from Danish Medicines AgencyGland Pharma ropes in Wriddhee Maitra as Vice-President (Human Resources)
CDSCO Panel Withholds Nod for Syngenes Pegfilgrastim Trial, Seeks Additional DataSyngene buys its first manufacturing facility in US for USD36.5 million
X